Torrent Pharma Gears Up to Launch Oral, Injectable Semaglutide in 2026 Post Patent Expiry: Report Farhat Nasim29 July 2025 10:09 PM ISTNew Delhi: Torrent Pharmaceuticals is preparing to introduce both oral and injectable versions of Semaglutide, a blockbuster diabetes and weight loss...
Dr Reddy's Labs plans to roll out cheaper Wegovy copycat across 87 countries in 2026: CEO Ruchika Sharma25 July 2025 4:30 PM ISTHyderabad: Dr. Reddy's Laboratories is gearing up to shake up the global weight-loss drug market with the launch of an affordable copycat version...
Delhi HC Flags Off-Label Use of Diabetes Drugs for Weight Loss, Seeks CDSCO Report Farhat Nasim3 July 2025 9:27 PM ISTNew Delhi: The Delhi High Court has directed the Central Drugs Standard Control Organisation (CDSCO) and the Drug Controller General of India (DCGI)...
Attention Healthcare professionals: WHO Issues Safety Alert on Semaglutide Use Dr. Kamal Kant Kohli1 July 2025 11:19 AM ISTGeneva: The World Health Organization (WHO) has issued a global safety alert highlighting the risk of non-arteritic anterior ischemic optic neuropathy...
New drug for diabetes and obesity shows promising results Dr. Kamal Kant Kohli24 Jun 2025 9:00 PM ISTLower blood sugar and increased fat burning - without negatively affecting appetite or muscle mass. These are some of the most promising effects of a...
Over Rs 2 Cr Semaglutide Theft at Dr Reddy's Srikakulam Unit, Staff Among 8 Arrested Farhat Nasim13 Jun 2025 6:17 PM ISTSrikakulam: In a serious breach of supply chain and internal controls, a group of eight individuals, including current and former pharmaceutical...
EMA flags rare vision risk with Semaglutide- a active substance in Ozempic, Rybelsus, Wegovy Ruchika Sharma7 Jun 2025 4:52 PM ISTEuropean Medicines Agency (EMA)'s safety committee (PRAC) has concluded its review of medicines containing semaglutide following concerns...
Delhi HC Restrains Dr Reddy's from Selling Semaglutide Drug in India Amid Novo Nordisk Row Ruchika Sharma31 May 2025 6:19 PM ISTNovo Nordisk has accused Dr Reddy's and OneSource of importing semaglutide API and using it to make and export formulations.
New study reveals potential link between GLP1 agonists and depression: Calls for urgent attention Dr. Kamal Kant Kohli24 April 2025 8:30 PM ISTA groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between Glucagon-like Peptide-1...
Novo Nordisk Withdrawal to Reshape Insulin Market; Lupin's Huminsulin to Gain Spotlight Farhat Nasim24 April 2025 6:29 PM ISTMumbai: Amidst the ongoing news of conventional insulin market disruption and growing concern over potential shortages triggered by Novo...
As Ozempic, Wegovy Take Priority, Novo Nordisk Winds Down Insulin Portfolio In India Farhat Nasim22 April 2025 7:04 PM ISTNew Delhi: Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand. This...
Medical Bulletin 22/ April/ 2025 Dr. Bhumika Maikhuri22 April 2025 3:00 PM ISTHere are the top medical news for the day:Can a Handful of Almonds Help Lower Cholesterol and Blood Sugar?A new consensus study has reinforced the...
